GT Biopharma Announces Interim GTB-3550 Trike Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference
57% of patients experienced significant reduction in AML/MDS cancer cell burden Up...
57% of patients experienced significant reduction in AML/MDS cancer cell burden Up...